Management Team

Claude has more than 30 years of experience in commercializing some of the most successful dermatology products in the world. He served as Vice President of Dermatology Sales at Medicis Pharmaceutical Corporation and has held various leadership positions in marketing and sales for therapeutic and aesthetic dermatology. He has executed more than 50 product launches during his career. In 2012, Valeant Pharmaceuticals International Inc. acquired Medicis for approximately $2.6B. Claude received his B.S. in Business and Marketing from Rutgers University.

Ramsey has more than 15 years of combined legal and business experience in the pharmaceutical and healthcare industry. Prior to joining the Company, Ramsey advised healthcare technology and life sciences companies on complex corporate transactions, including capital markets financings, mergers and acquisitions, and other strategic initiatives. Earlier in his career, he worked in the Aesthetics Division at Medicis Pharmaceutical Corporation until its acquisition by Valeant Pharmaceuticals (now Bausch Health) for $2.6 billion, and served as a legal fellow in the Division of Enforcement at the U.S. Securities and Exchange Commission in Washington, D.C. Ramsey received his LL.M. degrees from Georgetown University Law Center and his J.D. from the Shepard Broad College of Law.

Joe has over 25 years of financial and business experience, predominantly in the pharmaceutical industry. He previously served as Vice President, Corporate Controller and Principal Accounting Officer of Telligent Pharma Inc., a specialty generic pharmaceutical company, and Corporate Controller of Torrent Pharmaceuticals a U.S. subsidiary of the Torrent Group, a multinational pharmaceutical company. Joe held senior financial management positions of increasing responsibility from corporate controller to Vice President of Finance at Savient Pharmaceuticals, Adare Pharmaceuticals and Edenbridge Pharmaceuticals. He began his career in the public accounting sector at Baker Tilly Virchow Krause, LLP, and Ernst and Young working with a diverse client base. Joe is a graduate of Wilkes University where he earned a B.A. in Accounting.

Robert has more than 30 years of experience in pharmaceutical, lab and medical management, and oversees all sales, marketing, trade and managed care functions at Journey. He came to Journey from The Dermatology Alliance, where he served as Managing Partner for one of the nation’s largest independent physician associations in the specialty of dermatology. Robert received his B.S. in Business Administration and Finance from Seton Hall University.

Dr. Sidgiddi spent many years as a clinical practitioner and as a government medical officer in India before moving into the pharmaceutical industry. Dr. Sidgiddi has close to 25 years of experience as a physician researcher in NCE development, drug repositioning and translational medicine. His experience spans across multiple therapeutic areas of diabetology, oncology, medical nutrition, and dermatology. Prior to joining Journey, Dr. Sidgiddi was with Dr. Reddy’s Laboratories Inc. in New Jersey, leading their dermatology franchise to a successful 5 first-cycle NDA approvals. Among others, Dr. Sidgiddi has also led clinical and translational research at Abbott Nutrition R&D, and Connexios Life Sciences in India. His biggest achievement till date is the successful first-cycle approval of Emrosi by the USFDA, a project he led from its inception till date. Dr. Sidgiddi received his Bachelor of Medicine, Bachelor of Surgery (M.B.B.S) from Gulbarga University, and his M.D. (Clinical Pharmacology) with the first rank from Rajiv Gandhi University of Health Sciences, Bangalore in India.

Andrew has more than 17 years of experience in dermatology pharmaceuticals, previously working for Medicis Pharmaceutical and Valeant Pharmaceutical as a forecasting and analytics expert. He has been with Journey Medical since it was founded in 2014, assisting the company transition into a public listed company with its November 2021 IPO. Primary responsibilities include supply chain management, sales operations, forecasting, gross to net management, and asset acquisition. He has previous experience in investment banking and financial analysis. Andrew received his B.S. in Biomedical Engineering from Johns Hopkins University and his M.B.A. in Finance from Arizona State University.

Brian has more than 19 years of experience commercializing pharmaceuticals and medical devices, predominantly in dermatology. Prior to Journey, he held leadership roles in marketing and product development at Ulthera and Merz Aesthetics, helping launch and grow Ultherapy into a globally-recognized aesthetic dermatology brand. Brian received his B.S. in Visual Communications from Arizona State University and his M.B.A in International Business from Thunderbird School of Global Management.

Jessica has more than 22 years of experience in dermatology pharmaceuticals. She has been recognized for her consistent sales accomplishments during that time. Jessica has held leadership roles in sales training, marketing, and management. Prior to Journey, her experience includes Medicis, Valeant, PuraCap and Prugen Pharmaceuticals. Jessica received her B.A. in Communications from Palm Beach Atlantic University.